Skip to main content
Log in

Kinetics of a high dose of piretanide in renal failure

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The kinetics of piretanide was studied in patients with renal failure. After oral administration of a high dose of piretanide (96 mg), the pharmacokinetic parameters were: elimination rate constant 0.346±0.072 h−1, half life 2.00±0.35 h, and total plasma clearance 119.55±35.90 ml · min−1. Compared to the values obtained in adults with normal renal function, these results show a decrease in total plasma clearance, but conservation of the metabolic clearance which amounts to 45% of the total clearance in the healthy adult.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Beermann B, Dalen E, Lindstrom B (1977) Elimination of furosemide in healthy subjects and in those with renal failure. Clin Pharmacol Ther 22: 70–78

    Google Scholar 

  • Cutler RE, Forrey AW, Christopher TG, Kimpel BM (1974) Pharmacokinetics of furosemide in normal subjects and functionally anephric patients. Clin Pharmacol Ther 15: 588–596

    Google Scholar 

  • Huang CM, Atkinson AJ, Levin M, Levin N, Quintanilla A (1974) Pharmacokinetics of furosemide in advanced renal failure. Clin Pharmacol Ther 16: 659–666

    Google Scholar 

  • Lawrence JR, Ansari AF, Elliot HL, Summer DJ, Brunton GF, Whiting B, Whitesmith R (1978) Kinetic and dynamic comparison of piretanide and furosemide. Clin Pharmacol Ther 23: 558–565

    Google Scholar 

  • Marone C, Reubi FC (1980) Effects of a new diuretic (piretanide) compared with furosemide on renal diluting concentrating mechanisms in patients with the nephrotic syndrome. Eur J Clin Pharmacol 17: 165–171

    Google Scholar 

  • Merkel W, Bormann D, Mania D, Muschaweck R, Hropot M (1976) Piretanide (HOE 118), a new high ceiling salidiuretic. Eur J Med Chem Chim Ther 11: 399–406

    Google Scholar 

  • Pozet N, Hadj-Aissa A, Pellet M (1980) Activity of a new high efficiency diuretic in man: piretanide (HOE 118). Br J Clin Pharmacol 9: 577–583

    Google Scholar 

  • Rane A, Villeneuve JP, Stone WJ, Nies AS, Wilkinson GR, Branch RA (1978) Plasma binding and disposition of furosemide in the nephrotic syndrome and in uremia. Clin Pharmacol Ther 24: 199–207.

    Google Scholar 

  • Rupp W (1974) Pharmacokinetics and pharmacodynamics of lasix. Scott Med J 19: 5–13

    Google Scholar 

  • Tilstone WJ, Fine A (1978) Furosemide kinetics in renal failure. Clin Pharmacol Ther 23: 644–650

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brazier, J.L., Pozet, N., Faucon, G. et al. Kinetics of a high dose of piretanide in renal failure. Eur J Clin Pharmacol 21, 307–310 (1982). https://doi.org/10.1007/BF00637618

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00637618

Key words

Navigation